AMPA receptor antagonist

This page covers all AMPA receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting AMPA receptor (GluA1-GluA4).

Targets

AMPA receptor (GluA1-GluA4)

Marketed (1)

• Perampanel Oral Tablet · University of Arizona · Neurology
  Perampanel is a non-competitive AMPA receptor antagonist that reduces glutamate-mediated excitatory neurotransmission in the brain.

Phase 3 pipeline (1)

• E2007 (perampanel) · Eisai Inc. · Neurology
  Perampanel is a non-competitive AMPA receptor antagonist that reduces glutamate-mediated excitatory neurotransmission in the brain.

Patent intelligence

• ampa receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates